UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Understand the reasons for choosing a retirement plan over a 401k. Make informed decisions for a secure retirement.
23,531 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Bitcoin climbs on geopolitical optimism, with traders betting on a swift de-escalation. The market sees a surge in se...
Geopolitical turmoil lifts crude, pushing airlines to raise ticket prices and trim schedules. Travelers face higher c...
A newly released Justice Department file details how Jeffrey Epstein financed a Gates-connected ex-girlfriend for yea...
Eli Lilly has enjoyed rapid growth from GLP-1 drugs, but sky-high expectations invite questions about valuations. Thi...
A lithium tech company advances from pilot to commercial production with a faster, cleaner extraction process. Analys...
Today’s market shows a blend of volatility and opportunity. Planet Labs led a surge on strong earnings, while broader...
AST SpaceMobile and Rocket Lab fell roughly 4% intraday, then clawed back losses as markets rotated amid a volatile w...
Elon Musk has appointed Benji Taylor, formerly with Base and Aave, to head design for X as the platform races to inte...
JPMorgan downgraded Wix.com to Underweight and cut its price target to $91, citing slower core growth and volatile ma...
Zillow reports a strong start to 2026 with rising revenue and a bold pre-marketing push. The Zillow Preview program d...
Tesla stock jumps about 19% in the past month, renewing the old Sell in May debate as summer trading looms and moment...